首頁 > 市場調查報告書 > 醫療設備

生技設備以基因為基之藥物開發

市場調查報告書

商品編碼

1619095

無標定檢測市場規模、佔有率、成長分析、按產品、按技術、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Label Free Detection Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Bio-Layer Interferometry, Differential Scanning Calorimetry), By Application, By End-User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球無標定檢測市場規模為15億美元，從2023年的16.2億美元成長到2031年的30.5億美元，在預測期內（2024-2031年）預計將以複合年成長率成長。。

由於螢光和其他技術的進步，無需使用標籤即可研究生物分子交互作用，預計無標定檢測系統市場將顯著成長。這些系統有助於快速、即時的藥物發現，主要用於生化和基於細胞的測定。從 2021 年到 2028 年，旨在加強藥物發現計畫的產學界合作激增，預計將進一步推動市場擴張。此外，研究經費的增加和無標定技術固有的高靈敏度將支持成長。擴大製藥和生物技術研發領域，加上最終用戶對無標定方法優勢的認知不斷增強，確保了預測期內市場的強勁發展。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Agilent Technologies, Inc.（USA）
Danaher Corporation（USA）
PerkinElmer, Inc.（USA）
GE Healthcare（USA）
Thermo Fisher Scientific Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
F. Hoffmann-La Roche AG（Switzerland）
Horiba, Ltd.（Japan）
Malvern Panalytical Ltd.（UK）
Bruker Corporation（USA）
Waters Corporation（USA）
Shimadzu Corporation（Japan）
Corning Incorporated（USA）
Hitachi High-Tech Corporation（Japan）
Molecular Devices, LLC（USA）
Sartorius AG（Germany）
BiOptix Analytical LLC（USA）
Attana AB（Sweden）
XanTec Bioanalytics GmbH（Germany）

結論和建議

簡介目錄

Product Code: SQMIG35I2221

Global Label Free Detection Market size was valued at USD 1.5 billion in 2022 and is poised to grow from USD 1.62 billion in 2023 to USD 3.05 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The label-free detection systems market is poised for significant growth, driven by advancements in technology that enable the study of biomolecular interactions without auto-fluorescence or labels. These systems facilitate rapid, real-time drug discovery and are predominantly utilized in biochemical and cell-based assays. From 2021 to 2028, a surge in academic-industrial partnerships aimed at bolstering drug discovery programs is expected to further propel market expansion. Additionally, increased funding for research and the inherent high sensitivity of label-free technologies will support growth. The expanding pharmaceutical and biotechnology R&D landscape, coupled with rising awareness of label-free methods' advantages among end-users, will ensure robust market development throughout the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Label Free Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Label Free Detection Market Segmental Analysis

Global Label Free Detection Market is segmented by product, technology, application, end-user and region. Based on product, the market is segmented into consumables and instruments. Based on technology, the market is segmented into bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, surface plasmon resonance, mass spectrometry and other LFD technologies. Based on application, the market is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation and other. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Label Free Detection Market

The Global Label Free Detection market is poised for significant growth, driven largely by advancements in life sciences and the emergence of more sensitive technologies that do not rely on markers. The expansion of life sciences research in developing regions is creating a plethora of development opportunities for companies involved in this sector. Additionally, the introduction of innovative technological products and the increasing preference for efficient product delivery mechanisms are acting as catalysts for market growth. Label-free detection methods allow for the exploration of molecular interactions without the limitations associated with traditional labeling, such as quenching effects, spatial interference, or autofluorescence, making these technologies an attractive option in high throughput screening applications.

Restraints in the Global Label Free Detection Market

The global label-free detection market faces notable constraints that may impede its growth. A primary challenge is the elevated cost of the instruments required for label-free detection, which can deter potential users and limit market adoption. Additionally, the lack of awareness regarding the benefits and applications of label-free detection technologies further contributes to the market's slow expansion. This combination of high financial barriers and insufficient understanding hinders the market's ability to reach its full potential, preventing broader integration and acceptance of label-free detection methods across various sectors. Addressing these issues is crucial for facilitating market growth.

Market Trends of the Global Label Free Detection Market

The Global Label-Free Detection market is experiencing robust growth driven by technological innovations and strategic collaborations. Key techniques like bio-layer interferometry (BLI) and surface plasmon resonance (SPR) are gaining traction, with advancements such as Corning(R) Epic(R) BT leading the charge. This cutting-edge benchtop model streamlines cell-based and biochemical assays, boasts a competitive price, and features user-friendly data collection software, enabling greater accessibility for researchers, including those in academic settings. Partnerships, notably between Corning and Advinus Therapeutics, enhance market reach by facilitating drug discovery processes and assay services globally. As a result, the Label-Free Detection market is poised for significant expansion during the forecast period.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Label Free Detection Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
- Biosensor Chips
- Microplates
Instruments

Global Label Free Detection Market Size by Technology & CAGR (2024-2031)

Market Overview
Bio-Layer Interferometry
Differential Scanning Calorimetry
Isothermal Titration Calorimetry
Surface Plasmon Resonance
Mass Spectrometry
Other LFD Technologies

Global Label Free Detection Market Size by Application & CAGR (2024-2031)

Market Overview
Binding Kinetics
Binding Thermodynamics
Endogenous Receptor Detection
Hit Confirmation
Lead Generation
Other

Global Label Free Detection Market Size by End-User & CAGR (2024-2031)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

Global Label Free Detection Market Size & CAGR (2024-2031)

North America (Product, Technology, Application, End-User)
- USA
- Canada
Europe (Product, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Malvern Panalytical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi High-Tech Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiOptix Analytical LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Attana AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
XanTec Bioanalytics GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments